Comparison of two approaches to basal-bolus insulin therapy in patients with type 2 diabetes and inadequate glycemic control on oral therapy: comparison of premixed insulin lispro mid mixture with separate basal and bolus insulin injections.

Trial Profile

Comparison of two approaches to basal-bolus insulin therapy in patients with type 2 diabetes and inadequate glycemic control on oral therapy: comparison of premixed insulin lispro mid mixture with separate basal and bolus insulin injections.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Insulin glargine; Insulin lispro; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms IOOX
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Dec 2009 Patient numbers amended from 469 to 484 as reported by ClinicalTrials.gov.
    • 21 Oct 2009 Results presented at the 20th World Diabetes Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top